Aubrey Rankin's Net Worth
$11.5 Million
Who is Aubrey Rankin?
Aubrey Rankin has an estimated net worth of $11.5 Million. This is based on reported shares in Revance Therapeutics, Inc..
SEC CIK
Aubrey Rankin's CIK is 0001818576
Past Insider Trading and Trends
2020 was Aubrey Rankin's most active year for acquiring shares with 6 total transactions. Aubrey Rankin's most active month to acquire stocks was the month of June. 2021 was Aubrey Rankin's most active year for disposing of shares, totalling 8 transactions. Aubrey Rankin's most active month to dispose stocks was the month of June. 2021 saw Aubrey Rankin paying a total of $432,876.00 for 63,445 shares, this is the most they've acquired in one year. In 2021 Aubrey Rankin cashed out on 190,267 shares for a total of $5,356,055.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revance Therapeutics, Inc. (RVNC) Snapshot price: $5.375
President, Innovation & Tech
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.44% | -1.37K |
$15.79 | -$21,663.88 | 94.09K |
Mar 15
| |||
Form 4
| +45.83% | 30K |
$14.43 | $432,876.00 | 95.46K |
Dec 3
| |||
Form 4
| -17.94% | -14.31K |
$26.23 | -$375,431.98 | 65.46K |
Scheduled
|
Aug 15 - Aug 16
| ||
Form 4
| -10.25% | -54.33K |
$30.08 | -$1,632,960.00 | 475.91K |
Scheduled
|
Jul 28
| ||
Form 4
| -13.46% | -55.38K |
$29.72 | -$1,645,953.04 | 355.94K |
Scheduled
|
Jul 26
| ||
Form 4
| -0.00% | -2.00 |
$28.28 | -$56.56 | 411.32K |
Scheduled
|
Apr 5
| ||
Form 4
| -7.45% | -33.12K |
$25.43 | -$842,216.17 | 411.33K |
Scheduled
|
Mar 4
| ||
Form 4
| +17.54% | 11.9K |
—
|
—
| 79.78K |
Feb 2
| |||
Form 4
| -6.93% | -33.12K |
$25.95 | -$859,438.05 | 444.45K |
Scheduled
|
Feb 1
| ||
Form 4
| -6.49% | -33.12K |
$27.82 | -$921,211.61 | 477.56K |
Scheduled
|
Dec 30
| ||
Form 4
| -6.09% | -33.12K |
$23.85 | -$789,888.15 | 510.68K |
Scheduled
|
Nov 30
| ||
Form 4
| -5.74% | -33.12K |
$26.15 | -$865,949.25 | 543.8K |
Scheduled
|
Oct 29
| ||
Form 4
| -5.43% | -33.12K |
$26.18 | -$867,055.42 | 576.92K |
Scheduled
|
Sep 28
| ||
Form 4/A
| +6,283.35% | 667.29K |
—
|
—
| 677.91K |
Jul 23
| |||
Form 4
|
∞
| 667.29K |
—
|
—
| 667.29K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||